These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 13491837)

  • 21. Apropos 'Monitoring of poliovirus neutralizing antibodies in São Paulo State, Brazil'.
    Arya SC; Agarwal N
    Trans R Soc Trop Med Hyg; 2011 Feb; 105(2):118; author reply 118-20. PubMed ID: 21093002
    [No Abstract]   [Full Text] [Related]  

  • 22. Isolation of a non-infective antigen from preparations of poliomyelitis virus.
    AGOL VI; CHUMAKOVA MIa
    Probl Virol; 1961; 6():175-8. PubMed ID: 14036593
    [No Abstract]   [Full Text] [Related]  

  • 23. Poliomyelitis vaccination with live poliovirus.
    BUSER F; SCHAR M
    Am J Dis Child; 1961 May; 101():568-74. PubMed ID: 13689341
    [No Abstract]   [Full Text] [Related]  

  • 24. [STUDIES ON THE COMPLEMENT FIXATION REACTION FOR POLIOMYELITIS. IV. THE SEROLOGICAL CONSTITUTION OF DIFFERENT TYPE I AND TYPE II ANTIGENS].
    SCHMIDT WA
    Arch Gesamte Virusforsch; 1963 May; 13():358-67. PubMed ID: 14047327
    [No Abstract]   [Full Text] [Related]  

  • 25. [NEW METHODS ON THE CONCENTRATION AND PURIFICATION OF POLIO ANTIGENS].
    SCHMIDT WA
    Zentralbl Bakteriol Orig; 1963 Dec; 191():130-2. PubMed ID: 14119894
    [No Abstract]   [Full Text] [Related]  

  • 26. [Quantitative relationships between antigen concentration and serum titer in poliomyelitis virus neutralization test].
    DREES O; ROHDE B
    Zentralbl Bakteriol Orig; 1956 Jun; 166(2):84-9. PubMed ID: 13353534
    [No Abstract]   [Full Text] [Related]  

  • 27. Observations on the complement-fixing antibody response to poliovirus in patients with certain Coxsackie and ECHO virus infections.
    LENNETTE EH; SCHMIDT NJ; MAGOFFIN RL
    J Immunol; 1961 May; 86():552-60. PubMed ID: 13760855
    [No Abstract]   [Full Text] [Related]  

  • 28. [BEHAVIOR OF POLIO ANTIGENS IN THE ECTEOLA CELLULOSE ION-EXCHANGE ADSORBENT].
    SCHMIDT WA
    Arch Gesamte Virusforsch; 1963 May; 13():368-74. PubMed ID: 14046082
    [No Abstract]   [Full Text] [Related]  

  • 29. [The present status of poliomyelitis inoculation with live avirulent polio virus. Report from an information tour].
    BUSER F
    Schweiz Med Wochenschr; 1960 Jan; 90():44-7. PubMed ID: 13806390
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of live attenuated poliovirus vaccine.
    SKINNER RG
    J Fla Med Assoc; 1960 May; 46():1387-9. PubMed ID: 13831482
    [No Abstract]   [Full Text] [Related]  

  • 31. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINE. III. IS THERE INTERFERENCE BY SV 40 AGAINST POLIOVIRUS?].
    GUENTHER O; VON METTENHEIM ; HOEVEL H
    Zentralbl Bakteriol Orig; 1964 Feb; 192():1-11. PubMed ID: 14176847
    [No Abstract]   [Full Text] [Related]  

  • 32. Interference patterns encountered when using attenuated poliovirus vaccines.
    HALE JH; LEE LH; GARDNER PS
    Br Med J; 1961 Sep; 2(5254):728-32. PubMed ID: 13710702
    [No Abstract]   [Full Text] [Related]  

  • 33. Measurement of the protective effect of attenuated poliovirus vaccine.
    KNOWELDEN J; HALE JH; GARDNER PS; LEE LH
    Br Med J; 1961 May; 1(5237):1418-20. PubMed ID: 13757211
    [No Abstract]   [Full Text] [Related]  

  • 34. [THE PERSISTENCE OF POLIOMYELITIS VIRUS TYPE 1 IN VACCINATED INDIVIDUALS AND IN THEIR ENVIRONMENT].
    BILEK M; KOEENIG I; LUTYNSKI R
    Przegl Epidemiol; 1965; 19():97-100. PubMed ID: 14317139
    [No Abstract]   [Full Text] [Related]  

  • 35. The safety test for poliomyelitis vaccine. III. Comparative sensitivity of rhesus and vervet monkeys to poliovirus.
    VAN HOOSIER GL; BARON S; KIRSCHSTEIN RL; ABINANTI FR
    Am J Hyg; 1962 Jan; 75():86-9. PubMed ID: 13924586
    [No Abstract]   [Full Text] [Related]  

  • 36. Recent results of mass immunization against poliomyelitis with Koprowski strains of attenuated live poliovirus.
    PLOTKIN SA
    Am J Public Health Nations Health; 1962 Jun; 52(6):946-60. PubMed ID: 14487227
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antibody response to a vaccination against polio virus during treatment with isonicotinic acid hydrazide].
    PITZURRA M; CUSMA N; BISCATTI O; DONATI M
    Boll Soc Ital Biol Sper; 1962 Feb; 38():130-2. PubMed ID: 14487009
    [No Abstract]   [Full Text] [Related]  

  • 38. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424
    [No Abstract]   [Full Text] [Related]  

  • 39. [ACTION OF GUANIDINE ON POLIOMYELITIS VIRUSES].
    BROTZU G; FERRARI W
    Rass Med Sarda; 1964; 67():35-46. PubMed ID: 14164047
    [No Abstract]   [Full Text] [Related]  

  • 40. SURVIVAL OF VIRUSES OF THE ENTEROVIRUS GROUP (POLIOMYELITIS, ECHO, COXSACKIE) IN SOIL AND ON VEGETABLES.
    BAGDASARYAN GA
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():497-505. PubMed ID: 14238948
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.